Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment

Junbao Wei; Hengzong Zhu; Xiaoli Liao

doi:10.18632/oncotarget.24318

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meta-Analysis:

Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment

Junbao Wei _, Hengzong Zhu and Xiaoli Liao

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:14630-14641. https://doi.org/10.18632/oncotarget.24318

Metrics: PDF 1375 views | HTML 2240 views | ?

Abstract

Junbao Wei1,*, Hengzong Zhu2,* and Xiaoli Liao3

1Department of Therapeutic Radiology, Guangxi Autonomous Regional Cancer Hospital & Cancer Hospital of Guangxi Medical University, Nanning, 530021, China

2Department of General Medicine, Longan Hospital of Traditional Chinese Medicine, Nanning, 532700, China

3The Oncology Department, Guangxi Autonomous Regional Cancer Hospital & Cancer Hospital of Guangxi Medical University, Nanning, 530021, China

*These authors contributed equally to this work

Correspondence to:

Xiaoli Liao, email: [email protected]

Keywords: prostate cancer; recurrence; choline PET/CT; PSA; meta-analysis

Received: July 27, 2017 Accepted: December 13, 2017 Epub: January 24, 2018 Published: March 06, 2018

ABSTRACT

Purpose: To assess the relationship between the diagnostic accuracy of Choline positron emission tomography/computed tomography (PET/CT) and the trigger prostate-specific antigen (PSA) level in patients with a biochemical recurrence of prostate cancer.

Materials and Methods: A meta-analysis was conducted to synthesize data across multiple studies.

Results: The pooled sensitivity and specificity of choline PET/CT were 82% (95% Confidence Interval (CI):80–84%) and 92% (95%CI: 90–93%), respectively. The pooled sensitivity and specificity of ¹⁸F-choline PET/CT were 81% (95%CI: 78–84%) and 90% (95%CI: 85–93%), respectively. The pooled sensitivity and specificity of ¹¹C-choline PET/CT were 83% (95% CI: 80–86%) and 92% (95% CI: 90–94%), respectively. The pooled detection rate of ¹⁸F-choline PET/CT and ¹¹C-choline PET/CT were 58% (95% CI: 48–68%) and 58% (95%CI: 49–68%), respectively.

Conclusions: Trigger PSA is an important risk factor for positive findings of Choline PET/CT and the detection rate of Choline PET/CT for recurrent prostate cancer increased in parallel with raises in PSA-values. Choline PET/CT got higher detection rate while the trigger PSA > 2ng/ml.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24318

Publication Alerts

Post-Publication Promotion

Publication Discount

Meta-Analysis:

Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment

Abstract